“Dynamics into election look to be [a] perfect storm,” RBC analyst Brian Abrahams wrote, according to CNBC. “While GOP leaders do not see drug-pricing reform as a top priority, both [House Speaker Nancy] Pelosi and [President] Trump are very committed to having policy change. “
Mr. Abrahams said that the drug-pricing reform package is likely to be a “middle-of-the-road” policy change.
Escalating drug costs in the U.S. have become a major issue, with both Democrats and Republican lawmakers working on bills to curb costs. A bipartisan bill from Sens. Chuck Grassley, R-Iowa, and Ron Wyden, D-Ore., is making its way through the Senate.
Read the full report here.
More articles on pharmacy:
Pfizer to merge off-patent business with Mylan
Senate panel advances drug-pricing legislation
Average chief pharmacy officer salary by state
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
